TTP-889

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameTTP-889
Drug Alias NameTTP-889
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IXa inhibitors
TargetsCoagulation factor IX
Therapy Area/IndicationsHip FracturesVenous ThromboembolismEmbolism and Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaSwedenNorway +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVtv Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVtv Therapeutics
Active IndicationsN/A
Inactive IndicationsHip FracturesVenous ThromboembolismEmbolism and Thrombosis

Other Information

ATC CodeN/A
Related LinksDrugBank